See what members are saying about vitiligo treatments, the side effects to expect, and the drug basics.
All treatment information is medically reviewed · November 11, 2025
Opzelura (ruxolitinib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat nonsegmental vitiligo in adults and children 12 years and older.
Become a member to get even more